Valganciclovir and Risk for Neutropenia: When the Friend Becomes the Foe

Pediatr Transplant. 2024 Aug;28(5):e14817. doi: 10.1111/petr.14817.

Authors

Nadya Nalli¹, Chia Wei Teoh², Upton Allen³

Affiliations

¹ Department of Pharmacy, Transplant and Regenerative Medicine Centre, Hospital for Sick Children, Toronto, Ontario, Canada.
² Division of Nephrology, Department of Paediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
³ Division of Infectious Diseases, Department of Paediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

PMID: 39030959
DOI: 10.1111/petr.14817

No abstract available

Keywords: neutropenia; solid organ transplant; valganciclovir.

Publication types

Editorial
Letter

MeSH terms

Antiviral Agents* / adverse effects
Child
Cytomegalovirus Infections / complications
Ganciclovir* / therapeutic use
Humans
Neutropenia* / chemically induced
Risk Factors
Valganciclovir* / therapeutic use

Substances

Valganciclovir
Antiviral Agents
Ganciclovir